Furthermore, our previous study also indicated that CUX1 overexpression was significantly correlated with several clinicopathological features, such as P53 mutation, Ki67 expression, and WHO tumor grade (Wu et al., 2019). The gene discussed is CUX1; the disease is neoplasm.